Ranjit K. Mehta

810 total citations
12 papers, 628 citations indexed

About

Ranjit K. Mehta is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Ranjit K. Mehta has authored 12 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Materials Chemistry and 3 papers in Oncology. Recurrent topics in Ranjit K. Mehta's work include Heat shock proteins research (3 papers), Nanoparticles: synthesis and applications (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ranjit K. Mehta is often cited by papers focused on Heat shock proteins research (3 papers), Nanoparticles: synthesis and applications (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ranjit K. Mehta collaborates with scholars based in United States, India and Germany. Ranjit K. Mehta's co-authors include Avinash Sonawane, Rashmirekha Pati, Soumitra Mohanty, Mitali Sengupta, Avinash Padhi, Chandan Goswami, Rojalin Sahu, Ishani Das, Birendranath Banerjee and Satish V. Patil and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ranjit K. Mehta

12 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranjit K. Mehta United States 10 238 211 87 72 54 12 628
Dakshayani Lomada India 15 144 0.6× 135 0.6× 71 0.8× 38 0.5× 22 0.4× 28 625
Daisy Machado Brazil 18 97 0.4× 183 0.9× 96 1.1× 132 1.8× 32 0.6× 40 831
Moisés Ármides Franco-Molina Mexico 17 153 0.6× 341 1.6× 160 1.8× 126 1.8× 28 0.5× 69 904
Nelson Santiago Vispo Ecuador 16 108 0.5× 344 1.6× 179 2.1× 95 1.3× 17 0.3× 46 826
Edgar Mendoza-Gamboa Mexico 15 115 0.5× 196 0.9× 86 1.0× 68 0.9× 21 0.4× 27 709
Yuan-Chieh Yeh Taiwan 11 81 0.3× 244 1.2× 93 1.1× 51 0.7× 15 0.3× 21 635
Ching-Wen Huang Taiwan 6 141 0.6× 200 0.9× 141 1.6× 147 2.0× 18 0.3× 8 745
Musaed Alkholief Saudi Arabia 18 120 0.5× 195 0.9× 87 1.0× 219 3.0× 116 2.1× 41 844
Jelan A. Abdel-Aleem Egypt 12 160 0.7× 235 1.1× 190 2.2× 209 2.9× 18 0.3× 19 809
Pramila Chaubey India 16 141 0.6× 207 1.0× 67 0.8× 149 2.1× 78 1.4× 23 756

Countries citing papers authored by Ranjit K. Mehta

Since Specialization
Citations

This map shows the geographic impact of Ranjit K. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjit K. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjit K. Mehta more than expected).

Fields of papers citing papers by Ranjit K. Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjit K. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjit K. Mehta. The network helps show where Ranjit K. Mehta may publish in the future.

Co-authorship network of co-authors of Ranjit K. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjit K. Mehta. A scholar is included among the top collaborators of Ranjit K. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjit K. Mehta. Ranjit K. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mehta, Ranjit K., et al.. (2021). Disruptin, a cell-penetrating peptide degrader of EGFR. Translational Oncology. 14(8). 101140–101140. 5 indexed citations
2.
Bridges, Alexander J., et al.. (2021). Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?. Oncotarget. 12(11). 1032–1036. 4 indexed citations
3.
Surowiec, Rachel K., Carlos E. Espinoza, Ranjit K. Mehta, et al.. (2020). Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells. Molecular Cancer Research. 19(2). 223–239. 22 indexed citations
4.
Mehta, Ranjit K., Merna Sitto, Theresa P. Devasia, et al.. (2020). Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts. Clinical Cancer Research. 26(19). 5246–5257. 17 indexed citations
5.
Morishima, Yoshihiro, Ranjit K. Mehta, Miranda Lau, et al.. (2018). Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery. Molecular Pharmacology. 94(3). 984–991. 16 indexed citations
6.
Cuneo, Kyle C., et al.. (2018). Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib. Translational Oncology. 12(2). 209–216. 23 indexed citations
7.
Pati, Rashmirekha, Ishani Das, Ranjit K. Mehta, Rojalin Sahu, & Avinash Sonawane. (2016). Zinc-Oxide Nanoparticles Exhibit Genotoxic, Clastogenic, Cytotoxic and Actin Depolymerization Effects by Inducing Oxidative Stress Responses in Macrophages and Adult Mice. Toxicological Sciences. 150(2). 454–472. 108 indexed citations
8.
Ray, Paramita, Yee Sun Tan, Ranjit K. Mehta, et al.. (2016). Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors. Oncotarget. 7(42). 68597–68613. 16 indexed citations
9.
Pati, Rashmirekha, Ranjit K. Mehta, Soumitra Mohanty, et al.. (2014). Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomedicine Nanotechnology Biology and Medicine. 10(6). 1195–1208. 250 indexed citations
10.
Mehta, Ranjit K., et al.. (2014). Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(7). 1219–1230. 35 indexed citations
11.
Mehta, Ranjit K., Rashmirekha Pati, Mitali Sengupta, et al.. (2013). Mutations in Subunit Interface and B-cell Epitopes Improve Antileukemic Activities of Escherichia coli Asparaginase-II. Journal of Biological Chemistry. 289(6). 3555–3570. 32 indexed citations
12.
Mohanty, Soumitra, Ranjit K. Mehta, Rashmirekha Pati, et al.. (2013). Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages. Antimicrobial Agents and Chemotherapy. 57(8). 3688–3698. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026